ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0725

A Data Science Evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Questionnaire for Improving Management of JIA Patients

Humbert Quesada-Masachs1, Michalis Faloutsos2, Shomit Ghose3, Sara Marsal4, Consuelo Modesto4 and Estefania Quesada-Masachs5, 1University of California Riverside, San Diego, 2University of California Riverside, Riverside, 3University of California Berkeley, San Francisco, 4Hospital Universitari Vall d'Hebron, Barcelona, Spain, 5Hospital Universitari Vall d'Hebron, San Diego

Meeting: ACR Convergence 2020

Keywords: Disease Activity, Juvenile idiopathic arthritis, Patient reported outcomes, Pediatric rheumatology, quality of life

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Pediatric Rheumatology – Clinical Poster II: JIA

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a questionnaire developed to comprehensively assess Juvenile Idiopathic Arthritis (JIA) patients. Despite being translated into 54 languages, there is still limited literature about it. The length of the questionnaire could have been influencing its clinical practicality. The purpose of this study is to answer the following questions:

  1. “Which are the most informative questions?”;
  2. “How well do the collected data correlate with other clinical variables?”;
  3. “Are there discrepancies between the perceptions of patients and parents?”;

Methods: We included 71 children with JIA according to ILAR criteria, all of them receiving treatment and we followed them up for a year. JAMAR questionnaires were answered by both children and parents at baseline, 6 and 12 months. Also, a thorough clinical examination was performed in every visit: all the joints were clinically assessed for swelling, tenderness, and limited range of motion, and Juvenile Arthritis Disease Activity Score (JADAS), disease activity state, parents and patients assessment through Visual Analogue Scale (VAS), physician’s VAS, Erythrocyte Sedimentation Rate (ESR) and C-reactive protein (CRP) were recorded. We applied state of the art machine learning methods in order to find the most relevant questions in JAMAR. Additionally, we utilized tensor decomposition to identify relevant patient clusters. Furthermore, we correlated these critical questions with clinical and biological parameters recorded. We have compared the discordance rate between patients vs parents responses in 5 of JAMAR parameters as previously reported (Vanoni F, et al. Pediatr Rheumatol Online J. 2016;14(1):2). We explored the relation between discordance and demographic and clinical variables.

Results: A total of 374 JAMAR questionnaires are analyzed with our Machine Learning algorithms. First, we identify a small group of questions as the most relevant for patients and parents. The identified questions exhibit better correlations with the JADAS scores than the non-relevant ones. Second, 96% of the pairs (child-parent) are discordant for at least one item, but the differences are small and VAS well being is the only score with a statistically significant difference (P < 0.0001). We observe a higher rate of activity in the patients exhibiting discordant evaluations with their parents. In addition, the observation patient-parent agreement in Juvenile Arthritis Functionality Scale (JAFS) is better than Pediatric Rheumatology Quality of Life Scale (PRQL).

Conclusion: In this study, we revisit the JAMAR questionnaire by applying modern data mining techniques in a longitudinal dataset. Our results suggest that a small number of questions in the JAMAR questionnaire provide significant information and correlate well with the JADAS scores. We argue that this reduced set of questions could make the data collection easier by trading off the number of questions for frequency and ease of self-reported data collection.


Disclosure: H. Quesada-Masachs, None; M. Faloutsos, None; S. Ghose, None; S. Marsal, None; C. Modesto, None; E. Quesada-Masachs, None.

To cite this abstract in AMA style:

Quesada-Masachs H, Faloutsos M, Ghose S, Marsal S, Modesto C, Quesada-Masachs E. A Data Science Evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Questionnaire for Improving Management of JIA Patients [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/a-data-science-evaluation-of-the-juvenile-arthritis-multidimensional-assessment-report-jamar-questionnaire-for-improving-management-of-jia-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-data-science-evaluation-of-the-juvenile-arthritis-multidimensional-assessment-report-jamar-questionnaire-for-improving-management-of-jia-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology